GlaxoSmithKline plc's (GSK) Neutral Rating Reaffirmed at BNP Paribas


's stock had its "neutral" rating restated by analysts at BNP Paribas in a report issued on Friday, MarketBeat Ratings reports. They presently have a GBX 1,400 target price on the stock.



from Biotech News